Glancy Prongay Wolke & Rotter LLP continues its investigation into Alignment Healthcare, Inc. for possible violations of federal securities laws following a 16% stock price drop on July 8, 2026. A former chief transformation officer filed a whistleblower lawsuit alleging the company deliberately misclassified $8 million to $10 million in routine operating expenses as capital expenditures to artificially inflate adjusted EBITDA and report its first full year of positive adjusted EBITDA as a public company. On the news, Alignment’s stock fell $4.02, or 16.7%, to close at $20.03 per share, injuring investors.
Alignment Healthcare LLCWhistleblower lawsuit alleges misclassification of expenses to inflate EBITDA, triggering securities fraud investigation and 16.7% stock drop.